Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: In utero arsenic exposure and fetal immune repertoire in a US pregnancy cohort.

Authors: Nadeau, Kari C; Li, Zhigang; Farzan, Shohreh; Koestler, Devin; Robbins, David; Fei, Dennis Liang; Malipatlolla, Meena; Maecker, Holden; Enelow, Richard; Korrick, Susan; Karagas, Margaret R

Published In Clin Immunol, (2014 Dec)

Abstract: Arsenic has wide-ranging effects on human health and there is evidence that it alters the immune response by influencing CD4+/CD8+ T cell ratios, IL-2 cytokine levels, and the expression of immune-response genes. We investigated the impact of in utero environmental arsenic exposure on immune development and function in newborns participating in a pregnancy cohort in New Hampshire, U.S., where arsenic levels have exceeded the current EPA maximum contaminant level of 10 μg/L. Our results showed that maternal urinary arsenic concentrations were inversely related to absolute total CD45RA+ CD4+ cord blood CD69+ T cell counts (N=116, p=0.04) and positively associated with CD45RA+ CD69- CD294+ cell counts (p=0.01). In placental samples (N=70), higher in utero urinary arsenic concentrations were positively associated with the expression of IL1β (p=0.03). These data provide evidence that relatively low-level arsenic exposure in utero may alter the fetal immune system and lead to immune dysregulation.

PubMed ID: 25229165 Exiting the NIEHS site

MeSH Terms: Adult; Arsenic/adverse effects*; Female; Fetal Blood/cytology; Gene Expression; Humans; Immune System/drug effects*; Immune System/physiology*; Immunophenotyping; Infant, Newborn; Interleukin-1beta/genetics; Interleukin-1beta/metabolism; Lymphocyte Activation/immunology; Male; Maternal Exposure/adverse effects*; New Hampshire; Phenotype; Placenta/immunology; Placenta/metabolism; Pregnancy; Prenatal Exposure Delayed Effects/immunology*; Risk Factors; T-Lymphocyte Subsets/immunology; T-Lymphocyte Subsets/metabolism

to Top